In a recent study, the researchers suggested that targeting the circuits responsible for visual acuity may be necessary in achieving optimal recovery of visual function and could aid in the ...

Gore recently launched its silicone-free GORE IMPROJECT Plunger for 0.5-mL pre-filled syringes for the delivery of ophthalmic drugs. W. L. Gore and associates (Gore) announced the launch of its ...

Biotechnology company Lineage Cell Therapeutics recently announced it will be presenting data from its phase 1/2a clinical study (NCT02286089) at the upcoming Clinical Trials at the Summit (CTS) 2025 ...

The Retina World Congress 2025, led by President Barry Kuppermann, represents a pivotal moment in ophthalmological innovation, bringing together international retina specialists to discuss ...

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.

Ophthalmologist Tarek Hassan introduces new surgical approach for proliferative vitreoretinopathy, using precise small retinotomies instead of extensive retinal removal to improve patient outcomes.

Priya Vakharia, MD, a retina specialist at Retina Vitreous Associates of Florida in Tampa Bay, presented findings from the ARCHER trial investigating geographic atrophy (GA) treatment for dry ...

EyePoint Pharmaceuticals recently announced the enrollment and randomization of its phase 3 LUGANO trial (NCT06668064) of DURAVYU for the treatment of wet age-related macular degeneration (wet ...

Sophie X. Deng, MD, PhD, FARVO, has stepped into the role as the new 2025-2026 Association for Research and Ophthalmology (ARVO) president.. Deng has been part of ARVO for more than 20 years, is a ...

In a comprehensive study of geographic atrophy (GA) treatment, Deepak Sambhara, MD, from the Eye Clinic of Wisconsin analyzed long-term patient compliance with two recently FDA-approved complement ...

David Tanzer, MD, Lexitas Pharma Services' CMO, met up with Modern Retina® to chat during the 2025 Retina World Congress annual meeting. "This has been an amazing conference, and congratulations to ...

An investigation into incomplete retinal pigment epithelial and outer retinal atrophy (iRORA) identified a wide spectrum of fundus autofluorescence (FAF) patterns that corresponded with iRORA lesions ...